Oral laquinimod for treatment of relapsing-remitting multiple sclerosis

Lancet Neurol. 2008 Aug;7(8):672-3. doi: 10.1016/S1474-4422(08)70148-0.
No abstract available

Publication types

  • Letter

MeSH terms

  • Administration, Oral
  • Humans
  • Multiple Sclerosis, Relapsing-Remitting / drug therapy*
  • Quinolones / administration & dosage*

Substances

  • Quinolones
  • laquinimod